Biogen’s C.E.O. will step down after disastrous launch of Alzheimer’s drug.. Drugs (Pharmaceuticals), Aduhelm (Drug), Alzheimer's Disease, Medicare, Appointments and Executive Changes, Biogen Inc, Food and Drug Administration, European Union, Vounatsos, Michel